Benitec Biopharma Limited Research and Development Expense of Revenue

Research and Development Expense of Revenue of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development Expense of Revenue for the quarter ending June 30, 2022 was 0.0% (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development Expense of Revenue decreased by NaN%
  • Annual Research and Development Expense of Revenue for 2022 was 15441.1% (a 29.78% increase from previous year)
  • Annual Research and Development Expense of Revenue for 2021 was 11898.31% (a 0.0% decrease from previous year)
  • Annual Research and Development Expense of Revenue for 2021 was 11898.31% (a 304.41% increase from previous year)
  • Twelve month Research and Development Expense of Revenue ending June 30, 2022 was 15029.33% (a 9.65% increase compared to previous quarter)
  • Twelve month trailing Research and Development Expense of Revenue increased by Infinity% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
15029.33% 13706.58% 37944.83% 0.0%
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development Expense of Revenue of Benitec Biopharma Limited

Most recent Research and Development Expense of Revenueof BNTC including historical data for past 10 years.

Interactive Chart of Research and Development Expense of Revenue of Benitec Biopharma Limited

Benitec Biopharma Limited Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0% 4522.92% 15441.1%
2021 12584.0% 0.0% 116000.0% 275800.0% 11898.31%
2020 116800.0% 1407.27% -3261.11% 2875.0% 2942.16%
2019 777.92% 1281.82% 37.44%
2018 146.38%
2017 160.12% 62.43%
2016 43.44% 327.76%
2015 156.8%
2014 273.56%
2013 87.42%

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology